2022
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
Shi D, Whitaker M, Marks K, Anglin O, Milucky J, Patel K, Pham H, Chai S, Kawasaki B, Meek J, Anderson E, Weigel A, Henderson J, Lynfield R, Ropp S, Muse A, Bushey S, Billing L, Sutton M, Talbot H, Price A, Taylor C, Havers F, Team C. Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. MMWR Morbidity And Mortality Weekly Report 2022, 71: 574-581. PMID: 35446827, PMCID: PMC9042359, DOI: 10.15585/mmwr.mm7116e1.Peer-Reviewed Original ResearchMeSH KeywordsBNT162 VaccineChildCOVID-19EthnicityHospitalizationHumansMinority GroupsSARS-CoV-2United StatesConceptsCOVID-19-associated hospitalizationCOVID-19-Associated Hospitalization Surveillance NetworkIntensive care unitAge groupsUnvaccinated childrenPfizer-BioNTech COVID-19 vaccineCumulative hospitalization rateNon-Hispanic black childrenSevere COVID-19Immunization Practices recommendationsUnderlying medical conditionsCDC's Advisory CommitteeImportance of vaccinationEmergency use authorizationUnderlying health conditionsCOVID-19 vaccineCOVID-19SARS-CoV-2Advisory CommitteeCare unitHospitalization ratesVaccination coverageSevere outcomesChildren Aged 5Medical conditions
2021
Trends in Precancerous Cervical Lesions by Area-Based Measures of Poverty, Race, and Ethnicity, Connecticut, 2008-2018
Brackney MM, Weinberger DM, Higgins K, Meek J, Niccolai LM. Trends in Precancerous Cervical Lesions by Area-Based Measures of Poverty, Race, and Ethnicity, Connecticut, 2008-2018. Public Health Reports 2021, 137: 1146-1152. PMID: 34727517, PMCID: PMC9574305, DOI: 10.1177/00333549211056300.Peer-Reviewed Original ResearchConceptsPrecancerous cervical lesionsAverage annual percentage changeCervical lesionsArea-based measuresPublic Health Disparities Geocoding ProjectAge groupsHuman papillomavirus vaccinationJoinpoint regression softwareAnnual percentage changeActive surveillance systemHPV vaccinationPapillomavirus vaccinationBody of evidenceIncidence rateSociodemographic characteristicsLesionsYoung womenAnnual declineIncidence dataPercentage changeCut pointsWomenVaccinationCensus tract levelSurveillance system
2013
Niccolai et al. respond.
Niccolai LM, Julian PJ, Meek JI, Hadler JL, Sosa L. Niccolai et al. respond. American Journal Of Public Health 2013, 103: e4-5. PMID: 23947315, PMCID: PMC3780755, DOI: 10.2105/ajph.2013.301498.Peer-Reviewed Original ResearchIndividual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions
Niccolai LM, Russ C, Julian PJ, Hariri S, Sinard J, Meek JI, McBride V, Markowitz LE, Unger ER, Hadler JL, Sosa LE. Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions. Cancer 2013, 119: 3052-3058. PMID: 23661284, DOI: 10.1002/cncr.28038.Peer-Reviewed Original Research
2012
Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009.
Niccolai LM, Julian PJ, Bilinski A, Mehta NR, Meek JI, Zelterman D, Hadler JL, Sosa L. Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009. American Journal Of Public Health 2012, 103: 156-63. PMID: 22515856, PMCID: PMC3518345, DOI: 10.2105/ajph.2011.300447.Peer-Reviewed Original ResearchConceptsCervical intraepithelial neoplasia grade 2Human papillomavirus (HPV) vaccine impactStatewide surveillance dataCervical cancer precursorsAge-specific ratesVaccine impactCervical cancerCancer precursorsInverse associationVaccination strategiesGeographic measuresGrade 2Poisson regressionEthnic disparitiesSurveillance dataWomen